BioSpace News Archive

Drug Development

Inflammatory Bowel Disease Insight Report: Current Therapies, Drug Pipeline and Outlook

Inflammatory bowel disease (IBD) is an umbrella term for two conditions, Crohn’s disease and ulcerative colitis, that are characterized by chronic inflammation of the gastrointestinal (GI) tract. This chronic and prolonged inflammation results in damage to the GI tract.

November 18, 2019
·
33 min read
·
Tracy Lawton
Pharm Country

WCG Experts to Lead Nine Educational Sessions at the PRIM&R 2019 Advancing Ethical Research Conference

opics cover institutional review board (IRB) administration, research oversight, and research ethics

November 18, 2019
·
5 min read
Drug Development

Heart Failure Drug Developed by Merck and Bayer Meets Endpoints in Phase III Trial

The results of the Phase III VICTORIA trial set up the potential for the companies to seek regulatory approval for vericiguat.

November 18, 2019
·
2 min read
·
Alex Keown
Business

Dicerna Partners with Novo Nordisk on 30 Liver Disease Targets

They will leverage Dicerna’s GalXC RNAi technology platform to explore more than 30 liver cell targets.

November 18, 2019
·
2 min read
·
Mark Terry
Deals

Alkermes Buys Rodin Therapeutics to Bolster CNS Pipeline in $950 Million Deal

Under the terms of the deal, Alkermes is paying $100 million in cash upfront. Rodin will be eligible for future payments of up to $850 million based on clinical and regulatory milestones and sales thresholds.

November 18, 2019
·
3 min read
·
Mark Terry
Business

Novartis Cuts 150 Jobs As it Shifts Focus of Shanghai Facility to Drug Development

Three years after Novartis opened a $1 billion research & development facility in Shanghai, the company is shifting the focus of the site from drug discovery to commercial development.

November 18, 2019
·
2 min read
·
Alex Keown
Recipharm to communicate new financial targets on Capital Markets Day

has continued to grow and will present its strategy for profitable growth moving forward, together with new financial targets from 2020, at Capital Markets Day in Stockholm.

November 18, 2019
·
2 min read
CarThera to present update on SonoCloud-9 clinical study at upcoming SNO Congress in Phoenix, Arizona

Company recently received FDA approval for clinical trial; next generation device, SonoCloud-9, will soon be trialed in US

November 18, 2019
·
3 min read
FDA

FDA Approves Novartis’ Adakveo for Pain Events Associated with Sickle Cell Disease

“The approval of Adakveo marks a new era in the treatment of sickle cell disease, a genetic condition that places an extraordinary burden of unpredictable pain crises on patients and their families,” said Susanne Schaffert, president of Novartis Oncology.

November 18, 2019
·
2 min read
·
Mark Terry
Biotech Bay

Top 10 Biotech Bay Companies by Revenue

The companies included on this list are the top ten companies headquartered in Biotech Bay based on 2018 revenue.

November 18, 2019
·
9 min read
·
Stephanie DeClue